glp 1 agonist weight loss comparison Comparative efficacy and safety of GLP-1 receptor agonists for reduction: A model-based meta-analysis of placebo-controlled trials Unlocking The Power of GLP-1

Nausea, diarrhea, and vomiting were the most common events

Result: high adherence, slower initiation, lower commercial upside for premium brands

These drugs mimic the action of natural GLP-1, enhancing its beneficial effects on weight and blood sugar control

A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes

Semaglutide (Ozempic, Wegovy) may worsen diabetic retinopathy in patients with pre-existing retinal disease who experience rapid blood sugar improvements, but it does not directly damage eye structures

Weight loss can enhance insulin sensitivity and improve glycemic control in individuals with diabetes, reducing the need for higher doses of medication and potentially leading to diabetes remission in some cases